What LDN is, and why the dose matters
Naltrexone at 50 mg is FDA-approved for alcohol and opioid dependence, where it fully blocks opioid receptors. At one tenth to one thirtieth of that dose, the proposed effect is different: a brief, partial blockade that appears to prompt the body to increase its own endorphin and enkephalin signaling, plus a separate action on glial cells in the nervous system that reduces inflammatory signaling. That second mechanism is the reason LDN is studied in pain and immune conditions rather than in addiction. No manufacturer makes a low-dose tablet, so the capsule is compounded to the prescription, and the compounded product is not FDA-approved. The compounding and the law guide covers what a 503A pharmacy may prepare.
Fibromyalgia: the best-studied use
The most cited trial is a randomized, double-blind, placebo-controlled crossover study in 31 women with fibromyalgia, which reported a greater reduction in daily pain on LDN than on placebo. A later study in the same research group measured blood markers in fibromyalgia patients before and after eight weeks of LDN and found reduced levels of several pro-inflammatory cytokines, which is the kind of objective change the mechanism predicts. These are small studies from one group, and they measured pain and markers over weeks, not outcomes over years. They are the reason fibromyalgia is the condition LDN is most often prescribed for off-label.
Crohn’s disease: a positive pilot and a cautious review
An open-label pilot in 17 patients with active Crohn’s disease reported improvement in disease activity scores on LDN, and a placebo-controlled trial followed. The 2018 Cochrane review pooled what existed and concluded that the evidence was insufficient to allow firm conclusions about LDN for inducing remission, and that larger trials were needed. That is the honest reading: a promising signal, not an established therapy, and a gastroenterologist’s call in someone with Crohn’s.
Multiple sclerosis: quality of life, not disease course
An eight-week pilot trial in people with multiple sclerosis found improved mental-health quality-of-life scores on LDN compared with placebo, without changes in physical measures over that short window. Nothing in the published trials shows LDN altering the course of MS; what the pilot supports is a possible effect on how people feel day to day.
Chronic pain and inflammation more broadly
Two reviews pull the threads together. A 2014 review framed LDN as a novel anti-inflammatory approach to chronic pain and laid out the glial mechanism. A 2018 review of safety and efficacy across MS, fibromyalgia, Crohn’s disease and other chronic pain disorders found the safety profile favorable and the efficacy evidence encouraging but limited by small trials. If you read one thing about LDN, read one of those two rather than a forum thread.
What LDN is not
LDN is not a weight-loss medication in the published evidence. Naltrexone appears in an FDA-approved weight-management combination with bupropion, at a different dose and as a different product, and that approval does not transfer to compounded low-dose naltrexone on its own. LDN is also not a substitute for disease-modifying therapy in MS or for standard treatment in Crohn’s disease; in the trials it was studied alongside usual care, not instead of it.
What to expect if a clinician prescribes it
Most published protocols start around 1.5 mg daily and step up toward 4.5 mg over several weeks as tolerated. The trials measured effects over eight to twelve weeks, so a fair trial is a matter of weeks, and a clinician judges it by your symptoms and, where relevant, your labs. The most commonly reported side effects are vivid dreams and disturbed sleep, headache and nausea, usually mild and often easing as the dose settles. The one hard rule: LDN cannot be combined with opioid medications, including some pain and cough prescriptions, because naltrexone blocks them and can trigger withdrawal in someone taking them regularly.
At PepScribe, LDN is considered as one part of a whole-body wellness conversation: a free online visit, a US-licensed clinician who decides whether it fits your history, and if prescribed, one flat monthly plan set during the visit with the medication, the clinical care and shipping included. Every dose is compounded in the USA by licensed 503A pharmacies. No hidden overseas supply chain. The how to get LDN online guide walks that path step by step, and the LDN dosage guide covers the 4.5 mg the trials used. PepScribe names its dispensing pharmacies on the pharmacy partners page and shows how to verify its LegitScript certification on the trust page.
Frequently asked questions
What is low-dose naltrexone used for?
Off-label, for conditions with an inflammatory or immune component. The published trials cover fibromyalgia, Crohn's disease, multiple sclerosis and chronic pain more broadly. A clinician decides whether it is appropriate for you.
Does low-dose naltrexone work?
The trials are small. In fibromyalgia, a placebo-controlled crossover trial in 31 women reported less daily pain on LDN, and an eight-week study found reduced inflammatory cytokines. In Crohn's disease, a pilot was positive and the Cochrane review found the evidence insufficient for firm conclusions. In MS, a pilot found better mental-health quality of life. That is a promising signal, not proof.
How long does low-dose naltrexone take to work?
The trials measured effects over eight to twelve weeks. Expect a trial of weeks, with the dose stepped up along the way, and judge it with your clinician.
What are the side effects of low-dose naltrexone?
The most commonly reported are vivid dreams, disturbed sleep, headache and nausea, usually mild. It must not be combined with opioid medications.
Is low-dose naltrexone FDA-approved?
No. Naltrexone is FDA-approved as a 50 mg tablet for alcohol and opioid dependence. Compounded low-dose naltrexone is not an FDA-approved drug and is prescribed off-label.
How do I get low-dose naltrexone?
Through a licensed clinician and a compounding pharmacy. At PepScribe the online visit is free, a US-licensed clinician decides whether LDN fits your history, and if prescribed, a licensed 503A pharmacy compounds and ships it under one flat monthly plan.
